Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunity in Sequential Rhinovirus Infections
NCT02796001Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Sep 2017
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (3 arms), sponsored by University of Virginia. Primary endpoint: Virus Infection. Started Sep 2017; status: completed.
Beyond the preview
Go deeper on NCT02796001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796001.